Himmelreich Jeffrey C 4
4 · MAIA Biotechnology, Inc. · Filed Feb 12, 2025
Insider Transaction Report
Form 4
Himmelreich Jeffrey C
Head of Finance
Transactions
- Award
Stock Options
2025-02-10+10,000→ 10,000 totalExercise: $1.81Exp: 2035-02-10→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The stock options, granted on February 10, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months.